ProBioGen AG Contract Manufacturing & Development (CDMO) Profile
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines.
Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon.
With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.
CDMO Services:
Biologics; Cell & Gene Therapy Sterile Vials Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; Protein Vaccines; Viral Vector Vaccines
Year Founded: 1994
Head Office: Berlin, Germany
Number of Facilities: 1-2
Facility locations: Europe
Website: Visit the ProBioGen AG website
Linkedin: Connect on Linkedin
Current Capacity: 250L/1000L